This CME-accredited activity, the 2025 Seattle Lung Cancer Conference, brings together leaders in the field of thoracic oncology to provide an extensive overview of both current and emerging strategies for managing lung cancer (NSCLC and SCLC).

This CME-accredited activity, the 2024 Seattle Lung Cancer Conference, brings together leaders in the field of thoracic oncology to provide an extensive overview of both current and emerging strategies for managing lung cancer (NSCLC and SCLC).

The 4th Binaytara Precision Oncology Summit is an annual 2-day CME-accredited national conference that offers an unparalleled opportunity for oncology professionals to delve into the latest advancements, innovations, and practices in precision oncology.

This CME-accredited activity 2024 Napa Valley Lung Cancer Conference features leading experts in thoracic malignancies who will provide a comprehensive overview of current and emerging strategies for management of lung cancer (NSCLC, SCLC).

The 6th International Cancer Congress (ICC2024) is the 6th annual oncology conference organized by the Binaytara Foundation in Janakpurdham, Nepal.

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations

This accredited continuing education activity “Webcast-San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes”, is recorded from the live course held between 02/03-02/04/2023. 

This CME-accredited activity “San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes” features leading experts in thoracic malignancies who will provide a comprehensive overview of current an